According to Organogenesis Holdings Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 05:21 PM, company 10% Owner, Katz Michael W disclosed buying 20,829 shares at a cost of $3.25. At the time of this transaction (Nov 17), this trade was worth $67,694 in total. […]
According to Sally Beauty Holdings, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 05:19 PM, company Director, Rabin Edward W disclosed buying 4,000 shares at a cost of $11.04. At the time of this transaction (Nov 17), this trade was worth $44,163 in total. […]
According to Sally Beauty Holdings, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 05:19 PM, company Director, Rabin Edward W disclosed buying 4,000 shares at a cost of $10.73. At the time of this transaction (Nov 18), this trade was worth $42,936 in total. […]
According to Resideo Technologies, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 05:19 PM, company Director, Fradin Roger disclosed buying 6,666 shares at a cost of $15.00. At the time of this transaction (Nov 18), this trade was worth $99,990 in total. As of […]
According to Organogenesis Holdings Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 05:10 PM, company Director, Mackie Wayne D disclosed buying 42,726 shares at a cost of $3.25. At the time of this transaction (Nov 17), this trade was worth $138,860 in total. As […]
According to Greensky, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 05:07 PM, company President, Patient Solutions, Kelly Dennis I disclosed buying 27,000 shares at a cost of $4.07. At the time of this transaction (Nov 18), this trade was worth $109,944 in total. […]
According to Organogenesis Holdings Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 05:05 PM, company Director, Leibowitz Arthur S disclosed buying 6,943 shares at a cost of $3.25. At the time of this transaction (Nov 17), this trade was worth $22,565 in total. As […]
According to Organogenesis Holdings Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 04:55 PM, company Director, Nussdorf Glenn H disclosed buying 486,000 shares at a cost of $3.25. At the time of this transaction (Nov 17), this trade was worth $1,579,500 in total. As […]
According to Organogenesis Holdings Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 04:55 PM, company Director, Nussdorf Glenn H disclosed buying 347,153 shares at a cost of $3.25. At the time of this transaction (Nov 17), this trade was worth $1,128,247 in total. As […]
According to G1 Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 04:54 PM, company Director, Muir Glenn P disclosed buying 50,000 shares at a cost of $13.50. At the time of this transaction (Nov 18), this trade was worth $675,000 in total. As […]
PayPal Withdrawing Support For Kindle Fire, BlackBerry And Windows Phone
Revival Of Nashville Discussed
Brawl Erupts After Jose Bautista Downed By Rougned Odor Punch
VR Tour Offered Three Decades After Chernobyl Disaster
Kyle Busch Sweeps NASCAR Events At Martinsville
Halle Berry Enters The Social Media World
